Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Samolet is thinking about the IPO of the IT part of the business

7/4/24 SMLT

Samolet is working on the economic efficiency of sites in the Moscow region

7/4/24 SMLT

OGK-2 increased electricity generation by 16.2% in the 1st half of the year

7/4/24 OGKB

M.Video-Eldorado pilots multi-brand zones of premium home appliances

7/4/24 MVID

Shareholders of Diasoft approved dividends for 3 months 2024

7/4/24 DIAS

Resale Market will open branches in 30 regions of Russia

7/4/24 MGKL

Sber may acquire developer Ingrad

7/4/24 SBER

Sber may acquire developer Ingrad

7/4/24 INGR

Lenta is trying to launch its own alcohol.

7/4/24 LENT

Shareholders of Sistema approved dividends for 2023

7/3/24 AFKS